Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed<sup>®</sup> Versus Placebo

Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed<sup>®</sup> Versus Placebo

Xerostomia is a symptom frequently present in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM). In the present trial, the activity of an artificial saliva (aldiamed<sup>®</sup> spray) in comparison to a placebo spray were used to evaluate the xerostomia and the saliva anti...

Full description

Bibliographic Details
Main Authors: Bruna Sinjari, Beatrice Feragalli, Umberto Cornelli, Giovanni Belcaro, Ester Vitacolonna, Manlio Santilli, Imena Rexhepi, Gianmaria D’Addazio, Francesca Zuccari, Sergio Caputi
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
xerostomia
salivary flow
antioxidant capacity of saliva
aldiamed<sup>®</sup>
Online Access:https://www.mdpi.com/2077-0383/9/7/2196

Internet

https://www.mdpi.com/2077-0383/9/7/2196

Similar Items